CorMedix Inc. (CRMD) NASDAQ
8.66
+0.425(+5.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.66
+0.425(+5.16%)
Currency In USD
| Market Cap | 837.76M |
| Enterprise Value | 840.84M |
| P/E Ratio | 3.8 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.7 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 1.61 |
| Enterprise/EBITDA | 2.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.45 |
| Operating Margin | 0.48 |
| Return On Assets | 0.22 |
| Return On Equity | 0.5 |
| Revenue | 311.71M |
| Revenue/Share | 5.03 |
| Gross Profit | 275.75M |
| EBITDA | 165.13M |
| Net Income | 163.06M |
| Diluted EPS | 2.04 |
| Total Cash | 178.09M |
| Total Cash/Share | 2.24 |
| Total Debt | 144.89M |
| Total Debt/Equity | 0.33 |
| Current Ratio | 2.98 |
| Book Value Per Share | 5.5 |
| 52-Week Change | -30.09 |
| 52-Week High | 17.43 |
| 52-Week Low | 6.13 |
| Moving Average 50 Days | 7.55 |
| Moving Average 200 Days | 9.45 |
| Average Volume | 1.33M |
| Shares Outstanding | 78.45M |
| % Held by Institutions | 56.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | March 26, 2019 |